Pharmaco - Press Releases

Date	Title	Company
01-Nov-2023	CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK	CureVac
01-Nov-2023	Evotec SE to announce results for the first nine months 2023 on 08 November 2023	Evotec SE
01-Nov-2023	iOmx Therapeutics attends upcoming scientific and industry conferences	iOmx Therapeutics AG
01-Nov-2023	Spexis Announces Changes to the Executive Committee	Spexis AG
31-Oct-2023	LEO Pharma announces positive outcome of DELTA 3 open-label extension trial of delgocitinib cream in the treatment of adults with moderate to severe chronic hand eczema (CHE)	LEO Pharma
31-Oct-2023	PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED	PAION AG
31-Oct-2023	Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper	Mainz BioMed N.V.
31-Oct-2023	NICE recommends Novartis Cosentyx® (secukinumab) as the first biologic treatment for hidradenitis suppurativa (HS) since 2016	Novartis
31-Oct-2023	Fixed Phage rebrands to NexaBiome Limited, signifying commitment towards human health sector	NexaBiome Limited
31-Oct-2023	iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ	iOnctura
31-Oct-2023	Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights	Molecure S.A.
31-Oct-2023	Sosei Heptares Will Receive US$3.75 Million Payment in Multi-Target Partnership	Sosei Heptares
31-Oct-2023	Sosei Heptares Announces Submission of New Drug Application in Japan for Daridorexant (ACT-541468), a Dual Orexin Receptor Antagonist for the Treatment of Insomnia	Sosei Heptares
31-Oct-2023	CCDC Expands Global Talent Pool with Ghana-based Orgmento	Cambridge Crystallographic Data Centre (CCDC)
31-Oct-2023	Beckman Coulter Life Sciences and 10x Genomics Partner to Enable Single Cell Workflow Automation	Beckman Coulter Life Sciences
31-Oct-2023	Abingworth raises $356 million for new Clinical Co-Development Co-Investment Fund (CCD-CIF)	Abingworth
31-Oct-2023	EVERSANA® Earns Great Place to Work Recognition for Fifth Consecutive Year, Now Certified Across Seven Countries	EVERSANA®
31-Oct-2023	Straumann Group reports eleven percent organic revenue growth in the third quarter	Straumann Holding AG
31-Oct-2023	PolyPeptide signs scientific collaboration agreement	PolyPeptide Group
30-Oct-2023	Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024	Epigenomics AG